Thus far in the calendar year 2025, the stock price of GSK Pharma has zoomed 40 per cent, as against 1.8 per cent rise in BSE ...

Glaxo (GSK) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

In a report released today, Jo Walton from UBS maintained a Hold rating on GlaxoSmithKline (GSK – Research Report), with a price target of ...

Shareholders have already approved a pay increase for British American Tobacco chief executive Tadeu Marroco. He could ...

Dr. Ali Sherif normally gives about 50 doses of the measles vaccine to children each month at his clinic in Hobbs, New Mexico ...

Here's a portfolio of dividend shares that could produce £115 of monthly passive income for investors who maximise their ISA ...

Immediate resistance for the benchmark Nifty 50 Index is seen at 24545, while Support for the Nifty has shifted upwards to ...

LTIMindtree shares today climbed 1 per cent in early deals to hit a high of ₹4,585 per share. They, however, gave up gains ...

The boss of AstraZeneca said Europe should increase spending on health treatment in line with recent commitments on defence.

Benchmark NSE Nifty50 index was down 35.96 points at 24293.0, while the BSE Sensex was down 126.34 points at 79990.15. Among ...